Annual economic burden attributable to tobacco, by cause and country for 2020 (US$ millions)
| Economic burden (US$ millions) | Argentina | Brazil | Chile | Colombia | Costa Rica | Ecuador | Mexico | Peru | Total |
| Direct medical cost (%) | 2782.5 (52.3) | 9347.4 (38.5) | 1959.0 (45.0) | 1169.6 (50.6) | 285.1 (53.8) | 655.7 (49.5) | 5370.8 (59.6) | 1215.2 (45.8) | 22 785.4 (45.8) |
| Caregiver cost (%) | 1068.9 (20.1) | 6023.7 (24.8) | 1196.3 (27.5) | 519.0 (22.4) | 100.0 (18.9) | 312.2 (23.6) | 922.7 (10.2) | 700.1 (26.4) | 10 843.0 (21.8) |
| Productivity cost (%) | 1470.1 (27.6) | 8930.2 (36.7) | 1193.7 (27.4) | 624.6 (27.0) | 145.3 (27.4) | 355.5 (26.9) | 2720.7 (30.2) | 735.8 (27.8) | 16 175.7 (32.5) |
| Total economic burden | 5321.4 (100%) | 24 301.3 (100%) | 4349.0 (100%) | 2313.2 (100%) | 530.5 (100%) | 1323.4 (100%) | 9014.2 (100%) | 2651.1 (100%) | 49 804.2 (100%) |
| As a proportion of GDP | 1.3% | 1.9% | 1.8% | 0.9% | 0.9% | 1.3% | 0.9% | 1.3% | 1.4% |
| Proportion recovered through taxes | 25.4% | 9.4% | 27.1% | 14.3% | 8.8% | 7.3% | 22.5% | 4.4% | 14.9% |
| Direct medical cost (US$ millions) | |||||||||
| CV disease | 780.0 (28.0%) | 2280.4 (24.4%) | 505.3 (25.8%) | 362.2 (31.0%) | 118.1 (41.4%) | 274.4 (41.9%) | 1797.4 (33.5%) | 146.8 (12.1%) | 6264.6 (27.5%) |
| Stroke | 53.5 (1.9%) | 447.0 (4.8%) | 204.3 (10.4%) | 83.2 (7.1%) | 06.8 (2.4%) | 48.4 (7.4%) | 321.1 (6.0%) | 154.0 (12.7%) | 1318.3 (5.8%) |
| COPD | 521.4 (18.7%) | 4307.8 (46.1%) | 490.3 (25.0%) | 344.2 (29.4%) | 57.2 (20.1%) | 168.4 (25.7%) | 1995.0 (37.1%) | 452.0 (37.2%) | 8336.3 (36.6%) |
| Pneumonia | 16.6 (0.6%) | 31.2 (0.3%) | 01.3 (0.1%) | 04.9 (0.4%) | 01.4 (0.5%) | 02.2 (0.3%) | 55.5 (1.0%) | 04.5 (0.4%) | 117.6 (0.5%) |
| Lung cancer | 606.3 (21.8%) | 453.2 (4.8%) | 269.0 (13.7%) | 113.1 (9.7%) | 24.1 (8.4%) | 35.3 (5.4%) | 285.1 (5.3%) | 133.9 (11.0%) | 1920.0 (8.4%) |
| Other cancers | 481.9 (17.3%) | 751.8 (8.0%) | 263.8 (13.5%) | 127.0 (10.9%) | 44.1 (15.5%) | 49.9 (7.6%) | 288.2 (5.4%) | 185.1 (15.2%) | 2191.8 (9.6%) |
| Secondhand smoke | 322.7 (11.6%) | 1076.0 (11.5%) | 225.0 (11.5%) | 135.1 (11.6%) | 33.5 (11.7%) | 77.2 (11.8%) | 628.5 (11.7%) | 138.8 (11.4%) | 2636.8 (11.6%) |
| Total direct medical cost | 2782.5 (100%) | 9347.4 (100%) | 1959.0 (100%) | 1169.6 (100%) | 285.1 (100%) | 655.7 (100%) | 5370.8 (100%) | 1215.2 (100%) | 22 785.4 (100%) |
| Proportion of national health expenditure | 7.2% | 7.8% | 9.1% | 6.0% | 6.5% | 7.9% | 9.3% | 11.7% | 8.1% |
| Productivity cost (US$ millions) | = | ||||||||
| Premature death | |||||||||
| CV disease | 170.2 (25.4%) | 917.7 (26.4%) | 84.3 (19.6%) | 48.8 (19.9%) | 13.7 (29.3%) | 33.8 (28.1%) | 387.7 (36.5%) | 36.9 (12.0%) | 1693.2 (26.7%) |
| Stroke | 60.2 (9.0%) | 324.8 (9.4%) | 42.4 (9.9%) | 29.0 (11.8%) | 03.4 (7.2%) | 15.7 (13.0%) | 108.3 (10.2%) | 35.2 (11.5%) | 619.0 (9.7%) |
| COPD | 85.4 (12.8%) | 469.8 (13.5%) | 91.3 (21.3%) | 45.0 (18.4%) | 09.7 (20.6%) | 20.7 (17.2%) | 189.7 (17.8%) | 74.5 (24.2%) | 986.1 (15.5%) |
| Pneumonia | 29.2 (4.4%) | 161.7 (4.7%) | 08.9 (2.1%) | 04.9 (2.0%) | 01.6 (3.5%) | 07.1 (5.9%) | 59.7 (5.6%) | 18.3 (5.9%) | 291.4 (4.6%) |
| Lung cancer | 125.3 (18.7%) | 452.2 (13.0%) | 63.2 (14.7%) | 39.8 (16.3%) | 04.4 (9.5%) | 08.9 (7.4%) | 63.3 (6.0%) | 40.1 (13.0%) | 797.2 (12.5%) |
| Other cancers | 120.2 (18.0%) | 739.8 (21.3%) | 89.0 (20.7%) | 48.4 (19.8%) | 08.5 (18.2%) | 20.1 (16.7%) | 129.2 (12.2%) | 67.0 (21.8%) | 1222.1 (19.2%) |
| Secondhand smoke | 78.7 (11.8%) | 405.9 (11.7%) | 50.4 (11.7%) | 28.8 (11.8%) | 05.5 (11.7%) | 14.2 (11.8%) | 124.9 (11.8%) | 35.4 (11.5%) | 743.7 (11.7%) |
| Total premature deaths | 669.0 (100%) | 3471.8 (100%) | 429.6 (100%) | 244.7 (100%) | 46.9 (100%) | 120.4 (100%) | 1062.9 (100%) | 307.4 (100%) | 6352.8 (100%) |
| Disability | |||||||||
| CV disease | 116.8 (14.6%) | 1368.4 (25.1%) | 115.0 (15.0%) | 28.7 (7.6%) | 12.9 (13.1%) | 69.3 (29.5%) | 350.9 (21.2%) | 24.0 (5.6%) | 2086.0 (21.2%) |
| Stroke | 64.3 (8.0%) | 375.0 (6.9%) | 100.4 (13.1%) | 69.7 (18.3%) | 02.6 (2.6%) | 26.7 (11.4%) | 199.4 (12.0%) | 64.6 (15.1%) | 902.8 (9.2%) |
| COPD | 302.8 (37.8%) | 1544.7 (28.3%) | 287.9 (37.7%) | 163.5 (43.0%) | 32.5 (33.0%) | 77.9 (33.2%) | 598.0 (36.1%) | 232.9 (54.4%) | 3240.1 (33.0%) |
| Pneumonia | 00.3 (0.0%) | 00.9 (0.0%) | 00.0 (0.0%) | 00.0 (0.0%) | 00.0 (0.0%) | 00.1 (0.0%) | 00.5 (0.0%) | 00.1 (0.0%) | 01.8 (0.0%) |
| Lung cancer | 100.8 (12.6%) | 547.4 (10.0%) | 62.8 (8.2%) | 29.5 (7.8%) | 12.3 (12.5%) | 09.1 (3.9%) | 99.9 (6.0%) | 18.2 (4.2%) | 879.9 (9.0%) |
| Other cancers | 122.3 (15.3%) | 988.3 (18.1%) | 109.2 (14.3%) | 44.0 (11.6%) | 26.6 (27.0%) | 24.3 (10.3%) | 214.0 (12.9%) | 39.3 (9.2%) | 1567.9 (16.0%) |
| Secondhand smoke | 93.9 (11.7%) | 633.7 (11.6%) | 88.9 (11.6%) | 44.5 (11.7%) | 11.5 (11.7%) | 27.7 (11.8%) | 195.1 (11.8%) | 49.2 (11.5%) | 1144.5 (11.7%) |
| Total disability | 801.1 (100%) | 5458.4 (100%) | 764.1 (100%) | 379.8 (100%) | 98.4 (100.0%) | 235.1 (100%) | 1657.8 (100%) | 428.3 (100%) | 9822.9 (100%) |
| Premature death | 669.0 (45.5%) | 3471.8 (38.9%) | 429.6 (36.0%) | 244.7 (39.2%) | 46.9 (32.3%) | 120.4 (33.9%) | 1062.9 (39.1%) | 307.4 (41.8%) | 6352.8 (39.3%) |
| Disability | 801.1 (54.5%) | 5458.4 (61.1%) | 764.1 (64.0%) | 379.8 (60.8%) | 98.4 (67.7%) | 235.1 (66.1%) | 1657.8 (60.9%) | 428.3 (58.2%) | 9822.9 (60.7%) |
| Total productivity cost | 1470.1 (100%) | 8930.2 (100%) | 1193.7 (100%) | 624.6 (100%) | 145.3 (100%) | 355.5 (100%) | 2720.7 (100%) | 735.8 (100%) | 16 175.7 (100%) |
| Costs of caregivers (US$ millions) | |||||||||
| CV disease | 237.2 (22.2%) | 2160.5 (35.9%) | 252.8 (21.1%) | 82.1 (15.8%) | 36.6 (36.6%) | 91.9 (29.4%) | 249.3 (27.0%) | 50.6 (7.2%) | 3161.1 (29.2%) |
| Stroke | 94.8 (8.9%) | 530.0 (8.8%) | 179.1 (15.0%) | 93.3 (18.0%) | 03.5 (3.5%) | 41.1 (13.2%) | 135.9 (14.7%) | 115.9 (16.6%) | 1193.7 (11.0%) |
| COPD | 421.4 (39.4%) | 1918.1 (31.8%) | 473.7 (39.6%) | 228.3 (44.0%) | 36.4 (36.4%) | 116.9 (37.4%) | 359.7 (39.0%) | 369.4 (52.8%) | 3923.8 (36.2%) |
| Pneumonia | 09.9 (0.9%) | 39.0 (0.6%) | 03.0 (0.2%) | 01.2 (0.2%) | 00.3 (0.3%) | 01.8 (0.6%) | 06.0 (0.7%) | 07.6 (1.1%) | 68.8 (0.6%) |
| Lung cancer | 79.4 (7.4%) | 224.3 (3.7%) | 54.8 (4.6%) | 19.9 (3.8%) | 03.8 (3.8%) | 07.2 (2.3%) | 24.3 (2.6%) | 23.1 (3.3%) | 436.8 (4.0%) |
| Other cancers | 102.9 (9.6%) | 457.9 (7.6%) | 95.9 (8.0%) | 34.5 (6.6%) | 07.7 (7.7%) | 16.6 (5.3%) | 39.7 (4.3%) | 53.7 (7.7%) | 809.0 (7.5%) |
| Secondhand smoke | 123.3 (11.5%) | 693.8 (11.5%) | 136.9 (11.4%) | 59.8 (11.5%) | 11.7 (11.7%) | 36.7 (11.7%) | 107.8 (11.7%) | 79.8 (11.4%) | 1249.7 (11.5%) |
| Total cost of caregivers | 1068.9 (100%) | 6023.7 (100%) | 1196.3 (100%) | 519.0 (100%) | 100.0 (100%) | 312.2 (100%) | 922.7 (100%) | 700.1 (100%) | 10 843.0 (100%) |
COPD, chronic obstructive pulmonary disease; CV, cardiovascular; GDP, gross domestic product.